Blog
RSS FeedPosted by Michael Wonder on 14 Jul 2020
Aspen offers to cut cancer drug prices, may avoid EU antitrust fine
14 July 2020 - Aspen has offered to cut prices by an average of 73% for six off-patent cancer drugs, ...
Posted by Michael Wonder on 14 Jul 2020
PMPRB changes within scope of Patent Act, rules federal court in judicial review
13 July 2020 - The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the ...
Posted by Michael Wonder on 11 Jul 2020
Trump will sign three executive orders on lowering drug prices: chief of staff
10 July 2020 - President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief ...
Posted by Michael Wonder on 10 Jul 2020
Proposal to modify PHARMAC’s approach to competitive procurement
10 July 2020 - PHARMAC is proposing to standardise the way that it contracts for pharmaceuticals as a result of ...
Posted by Michael Wonder on 09 Jul 2020
Despite the pandemic, prices for many drugs keep rising
9 July 2020 - Despite the economic hardships the COVID-19 pandemic has created for many Americans, drug makers raised list ...
Posted by Michael Wonder on 09 Jul 2020
International regulators align positions on phase 3 COVID-19 vaccine trials
9 July 2020 - Medicines regulatory authorities from around the world have published a report today highlighting the outcomes ...
Posted by Michael Wonder on 09 Jul 2020
PHARMAC to remove medicine dispensing restrictions
9 July 2020 - Most funded medicines will return to all at once dispensing because PHARMAC is removing most of ...
Posted by Michael Wonder on 08 Jul 2020
House proposes $3.2 billion for FDA in FY 2021
7 July 2020 - On Monday, the US House Committee on Appropriations’ Subcommittee on Agriculture, Rural Development, Food and Drug ...
Posted by Michael Wonder on 07 Jul 2020
Lessons from the impact of price regulation on the pricing of anti-cancer drugs in Germany
7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...
Posted by Michael Wonder on 06 Jul 2020
Launch of public consultation on joint network strategy to 2025
6 July 2020 - EMA and the Heads of Medicines Agencies have developed a joint strategy for the next five ...
Posted by Michael Wonder on 02 Jul 2020
Cochlear calls for low risk health apps to be exempt from TGA register
3 July 2020 - Hearing implant giant Cochlear has called for some low risk health apps to be exempt from ...
Posted by Michael Wonder on 02 Jul 2020
Reduced annual charges for medical devices listed on the prostheses list
2 July 2020 - In response to the suspension of elective surgery due to COVID-19 and the significant impact this has ...
Posted by Michael Wonder on 01 Jul 2020
Some U.S. government contracts for COVID-19 research could skirt affordable pricing laws
1 July 2020 - A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research ...
Posted by Michael Wonder on 01 Jul 2020
International regulators provide guiding principles for COVID-19 clinical trials
1 July 2020 - EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International ...
Posted by Michael Wonder on 30 Jun 2020
EMA and Korean Ministry of Food and Drug Safety to share confidential COVID-19 information
30 June 2020 - EMA and the Ministry of Food and Drug Safety of the Republic of Korea have signed ...